1. Home
  2. PURR vs EMBC Comparison

PURR vs EMBC Comparison

Compare PURR & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PURR

Hyperliquid Strategies Inc

N/A

Current Price

$4.31

Market Cap

576.4M

Sector

Health Care

ML Signal

N/A

Logo Embecta Corp.

EMBC

Embecta Corp.

HOLD

Current Price

$9.10

Market Cap

602.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PURR
EMBC
Founded
2025
1924
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
576.4M
602.3M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
PURR
EMBC
Price
$4.31
$9.10
Analyst Decision
Strong Buy
Buy
Analyst Count
2
2
Target Price
$7.23
$18.50
AVG Volume (30 Days)
3.1M
918.3K
Earning Date
01-01-0001
05-11-2026
Dividend Yield
N/A
6.36%
EPS Growth
N/A
20.90
EPS
N/A
0.74
Revenue
N/A
N/A
Revenue This Year
N/A
$1.17
Revenue Next Year
$148.78
N/A
P/E Ratio
N/A
$12.79
Revenue Growth
N/A
N/A
52 Week Low
$3.01
$9.20
52 Week High
$5.78
$15.55

Technical Indicators

Market Signals
Indicator
PURR
EMBC
Relative Strength Index (RSI) 49.12 28.44
Support Level $3.17 N/A
Resistance Level $5.78 $10.88
Average True Range (ATR) 0.41 0.33
MACD 0.02 -0.07
Stochastic Oscillator 34.99 3.26

Price Performance

Historical Comparison
PURR
EMBC

About PURR Hyperliquid Strategies Inc

Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. HSI aims to provide capital-efficient and productive access to the HYPE token for U.S. and institutional investors, generating compounding shareholder returns that individual holders may not be able to replicate through staking, yield optimization, and active ecosystem engagement. HSI is positioned to become the largest HYPE-focused digital asset treasury vehicle capitalizing on Hyperliquid's rapid growth and providing exposure to one of the largest and fastest growing revenue pools in digital assets.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: